173 related articles for article (PubMed ID: 18691883)
1. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
Hartel M; Narla G; Wente MN; Giese NA; Martignoni ME; Martignetti JA; Friess H; Friedman SL
Eur J Cancer; 2008 Sep; 44(13):1895-903. PubMed ID: 18691883
[TBL] [Abstract][Full Text] [Related]
2. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
[TBL] [Abstract][Full Text] [Related]
3. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
[TBL] [Abstract][Full Text] [Related]
4. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
5. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
6. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
DiFeo A; Feld L; Rodriguez E; Wang C; Beer DG; Martignetti JA; Narla G
Cancer Res; 2008 Feb; 68(4):965-70. PubMed ID: 18250346
[TBL] [Abstract][Full Text] [Related]
7. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
[TBL] [Abstract][Full Text] [Related]
10. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
[TBL] [Abstract][Full Text] [Related]
12. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
Shi J; Hu Z; Pabon K; Scotto KW
Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
14. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
[TBL] [Abstract][Full Text] [Related]
15. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
[TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
[TBL] [Abstract][Full Text] [Related]
17. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression.
Marrero-Rodríguez D; Taniguchi-Ponciano K; Jimenez-Vega F; Romero-Morelos P; Mendoza-Rodríguez M; Mantilla A; Rodriguez-Esquivel M; Hernandez D; Hernandez A; Gomez-Gutierrez G; Muñoz-Hernandez N; la Cruz HA; Vargas-Requena C; Díaz-Hernández C; Serna-Reyna L; Meraz-Rios M; Bandala C; Ortiz-Leon J; Salcedo M
Tumour Biol; 2014 Nov; 35(11):11399-407. PubMed ID: 25119587
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
